Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075158
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075158
Neutralizing Antibody Market, By Antibody Type, By Target Virus, By End Use, By Distribution Channel, By Geography
PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Neutralizing Antibody Market is estimated to be valued at USD 265.40 Bn in 2026 and is expected to reach USD 478.96 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 265.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 478.96 Bn |
Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.
Market Dynamics:
The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market
Neutralizing Antibody Market Detailed Segmentation:
- By Antibody Type (Revenue, USD Bn, 2021 - 2033):
- Monoclonal Antibodies
- Polyclonal Antibodies
- By Target Virus (Revenue, USD Bn, 2021 - 2033):
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
- By Application (Revenue, USD Bn, 2021 - 2033):
- Therapeutics
- Diagnostics
- Research and Development
- By End User (Revenue, USD Bn, 2021 - 2033):
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033):
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.
Product Code: CMI5898
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Neutralizing Antibody Market , By Antibody Type, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Bn)
5. Neutralizing Antibody Market , By Target Virus, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
6. Neutralizing Antibody Market , By Application, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
7. Neutralizing Antibody Market , By End User, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
8. Neutralizing Antibody Market , By Distribution Channel, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2026,(US$ Billion)
9. Neutralizing Antibody Market , By Region, 2021-2026, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2026,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2026,(US$ Bn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
10. Competitive Landscape
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.